The Application Value of Ultrasound Imaging in the Differential Diagnosis of Benign and Malignant Breast Nodules of BI-RADS 3 and Above

Abstract

Objective: To explore the diagnostic value of ultrasound imaging for breast nodules of breast imaging-reporting and data system (BI-RADS) category 3 and above. Methods: From June 2021 to July 2022, 163 patients with breast nodules of BI-RADS 3 or above were selected as the research subjects. After pathological diagnosis, 24 cases were malignant breast nodules of BI-RADS 3 or above, while 139 cases were benign breast nodules of BI-RADS 3 or above. The diagnosis rate of malignant and benign breast nodules of BI-RADS 3 or above, including 95% CI, was observed and analyzed. Results: The malignant and benign detection rates of conventional ultrasound were 88.63% and 75.00%, respectively, and the malignant and benign detection rates of ultrasound imaging were 93.18% and 87.50%, respectively, with 95% CIs greater than 0.7. Conclusion: Ultrasound imaging can help improve the diagnostic accuracy of benign and malignant breast nodules of BI-RADS 3 and above and reduce the misdiagnosis rate.